We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MFC:NYSEManulife Financial Corporation analysis

Data as of Sep 28, 2026 - not real-time

Latest price
$43.50
Risk: low
3/10Low risk

Summary

At $43.50, Manulife Financial Corporation shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have lost 2.2%. With RSI at 48.7 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $41.91 and resistance around $44.88.
Valuation screens as overvalued: a P/E of 16.7 sits in line with the sector average of 15.4. Sell-side targets cluster 20.9% below the current quote. Revenue is growing at 10.7% on a 20.3% profit margin. The 3.11% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 18.7%, a beta of 0.73 and a maximum drawdown of 13.4%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top market events

  • Updated Sep 1, 2026 0 C$ unless otherwise stated...
  • Read Manulife Financial Corporation MFC Q2 FY2026 earnings call transcript on Yahoo Finance to keep your investing...
  • Manulife MFC reported earnings 30 days ago.

Market outlook

Short term

< 1 year

Neutral

Model confidence2/102 out of 10

Key factors

  • Trading above the 200-day average of 39.11
  • MACD momentum is negative
  • RSI at 48.7 is in neutral territory

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • P/E of 16.7 versus sector average of 15.4
  • Trading above the 200-day average of 39.11
  • Analyst targets imply -20.9% versus the current price

Long term

> 3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • P/E of 16.7 versus sector average of 15.4
  • Analyst targets imply -20.9% versus the current price
  • Profit margin of 20.3% is healthy

Key metrics

Financial health

Revenue Growth10.70%
Profit Margin20.31%
P/E Ratio16.7
ROE13.31%
ROA0.60%
Debt/Equity42.48
P/B Ratio2.0
Op. Cash Flow$31.0B
Free Cash Flow$1.5B
Industry P/E15.4

Technical analysis

TrendNeutral
RSI48.7
Support$41.91
Resistance$44.88
MA 20$43.64
MA 50$43.68
MA 200$39.11
MACDBearish
VolumeDecreasing
Fear & Greed Index92.73

Valuation

Fair Value$23.22
Target Price$34.41
Upside/Downside-20.90%
GradeOvervalued
TypeBlend
Dividend Yield3.11%

Risk assessment

Beta0.73
Volatility18.67%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.